首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors
【24h】

Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors

机译:在空间上不同的良性人类表皮肿瘤中的多个致癌突变和克隆关系

获取原文
获取原文并翻译 | 示例
           

摘要

Malignant tumors result from the accumulation of genetic alterations in oncogenes and tumor suppressor genes. Much less is known about the genetic changes in benign tumors. Seborrheic keratoses (SK) are very frequent benign human epidermal tumors without malignant potential. We performed a comprehensive mu-tational screen of genes in the FGFR3-RAS-MAPK and phosphoino-sitide 3-kinase (PI3K)-AKT pathways from 175 SK, including multiple lesions from each patient. SK commonly harbored multiple bona fide oncogenic mutations in FGFR3. PIK3CA, KRAS, HRAS, EGFR, and AKT1 oncogenes but not in tumor suppressor genes TSC1 and PTEN. Despite the occurrence of oncogenic mutations and the evidence for downstream ERK/MAPK and PI3K pathway signaling, we did not find induction of senescence or a DNA damage response. Array comparative genomic hybridization (aCGH) analysis revealed that SK are genetically stable. The pattern of oncogenic mutations and X chromosome inactivation departs significantly from randomness and indicates that spatially independent lesions from a given patient share a clonal relationship. Our findings show that multiple oncogenic mutations in the major signaling pathways involved in cancer are not sufficient to drive malignant tumor progression. Furthermore, our data provide clues on the origin and spread of oncogenic mutations in tissues, suggesting that apparently independent (multicentric) adult benign tumors may have a clonal origin.
机译:恶性肿瘤是由于癌基因和抑癌基因的遗传改变积累所致。关于良性肿瘤的遗传变化知之甚少。脂溢性角化病(SK)是非常常见的良性人类表皮肿瘤,无恶性潜能。我们对来自175 SK的FGFR3-RAS-MAPK和磷酸肌醇3-激酶(PI3K)-AKT通路中的基因进行了全面的突变筛选,包括每个患者的多个病变。 SK通常在FGFR3中含有多个真正的致癌突变。 PIK3CA,KRAS,HRAS,EGFR和AKT1癌基因,但在肿瘤抑制基因TSC1和PTEN中不存在。尽管发生了致癌突变,并且有下游ERK / MAPK和PI3K信号通路的证据,但我们并未发现衰老或DNA损伤反应的诱导。阵列比较基因组杂交(aCGH)分析表明,SK具有遗传稳定性。致癌突变和X染色体失活的模式与随机性大相径庭,表明来自给定患者的空间独立病变具有克隆关系。我们的发现表明,参与癌症的主要信号通路中的多个致癌突变不足以推动恶性肿瘤的进展。此外,我们的数据提供了有关组织中致癌突变的起源和扩散的线索,这表明显然独立的(多中心)成人良性肿瘤可能具有克隆起源。

著录项

  • 来源
  • 作者单位

    Department of Dermatology, University of Regensburg, 93042 Regensburg, Germany;

    Servei de Dermatologia, Hospital del Mar-Institut Municipal d'Investigacio Medica, Universitat Autonoma de Barcelona, 08003 Barcelona, Spain;

    Servei de Dermatologia, Hospital del Mar-Institut Municipal d'Investigacio Medica, Universitat Autonoma de Barcelona, 08003 Barcelona, Spain;

    Grupo de Carcinogenesis Epitelial, Programa de Patologia Molecular,Centra Nacional de Investigaciones Oncologicas (CNIO), 28029 Madrid, Spain;

    Grupo de Carcinogenesis Epitelial, Programa de Patologia Molecular,Centra Nacional de Investigaciones Oncologicas (CNIO), 28029 Madrid, Spain;

    Grupo de Citogenetica Molecular and Centra de Investigacion Biomedica en Red de Enfermedades Raras, Programa de Genetica del Cancer, Centra Nacional de Investigaciones Oncologicas, 28029 Madrid, Spain;

    Grupo de Carcinogenesis Epitelial, Programa de Patologia Molecular,Centra Nacional de Investigaciones Oncologicas (CNIO), 28029 Madrid, Spain;

    Grupo de Genetica Humana and Centra de Investigacion Biomedica en Red de Enfermedades Raras, Programa de Genetica del Cancer Humano, Centra Nacional de Investigaciones Oncologicas, 28029 Madrid, Spain;

    Grupo de Epidemiologia Genetica y Molecular, Programa de Genetica del Cancer, Centra Nacional de Investigaciones Oncologicas, 28029 Madrid, Spain;

    Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St. James's University Hospital,Leeds LS9 7TF, United Kingdom;

    Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St. James's University Hospital,Leeds LS9 7TF, United Kingdom;

    Grupo de Citogenetica Molecular and Centra de Investigacion Biomedica en Red de Enfermedades Raras, Programa de Genetica del Cancer, Centra Nacional de Investigaciones Oncologicas, 28029 Madrid, Spain;

    Institute of Pathology, University of Erlangen, 91054 Erlangen, Germany;

    Department of Dermatology, University of Regensburg, 93042 Regensburg, Germany;

    Department of Dermatology, University of Regensburg, 93042 Regensburg, Germany;

    Servei de Dermatologia, Hospital del Mar-Institut Municipal d'Investigacio Medica, Universitat Autonoma de Barcelona, 08003 Barcelona, Spain;

    Grupo de Carcinogenesis Epitelial, Programa de Patologia Molecular,Centra Nacional de Investigaciones Oncologicas (CNIO), 28029 Madrid, Spain,Departament de Ciencies Experimentals i de la Salut, Universitat Pompeu Fabra, 08003 Barcelona, Spain;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号